Sarissa Capital Management
Investment Details
Investor Type
Hedge Fund
Asset Class Focus
Healthcare, Biotechnology, Pharmaceuticals, Medical Devices
Stage Focus
Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, France, Italy, Denmark, Switzerland, Spain, South Korea, Ireland, Netherlands, Sweden, Belgium, Norway, Finland
Industries Focus
- Healthcare
- Healthcare Services
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Consumer Health
- Medical Equipment
- Healthcare IT
- Healthcare Real Estate
- Healthcare Distribution
- Healthcare Logistics
- Healthcare Consulting
- Healthcare Insurance
Investment Size:
50,000,000 to 500,000,000 USD
Investor Details Founded: 2012
Sarissa Capital Management is a hedge fund based in Greenwich, Connecticut, specializing in event-driven investments within the healthcare sector. The firm focuses on pharmaceutical, biotechnology, and medical device companies, employing strategies that capitalize on significant corporate events such as mergers, acquisitions, and regulatory changes. By analyzing these events, Sarissa aims to generate alpha for its investors.
The firm's investment approach is active and owner-oriented, often engaging with management teams and shareholders to unlock value and drive operational improvements within portfolio companies. Sarissa seeks to optimize healthcare companies to efficiently provide important medicines to society and increase the impact of medical innovation, while also generating value for shareholders.
Sarissa Capital Management has a track record of shareholder activism, notably engaging with companies like Amarin Corporation and Alkermes plc to influence strategic decisions and enhance shareholder value. The firm's portfolio includes investments in companies such as Attralus, demonstrating its commitment to impactful healthcare investments. Sarissa's team comprises subject matter experts dedicated to creating positive outcomes for investors, shareholders, and patients through thoughtful engagement and strategic initiatives.
Requirements
- Healthcare focus
- Event-driven investment opportunities
- Active engagement with portfolio companies
- Long-term capital appreciation
- Operational improvements within portfolio companies
- Shareholder value enhancement
- Strategic initiatives like asset sales, licensing deals, or management changes
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Attralus
Claim this Investor
Are you an official representative of Sarissa Capital Management?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim